Andrew Fuller1, Hassan Razvi1, John D Denstedt1, Linda Nott1, Ad Hendrikx2, Michael Luke3, S K Pal4, Jean de la Rosette1. 1. Division of Urology, Department of Surgery, Western University, London, ON; 2. Department of Urology, Catharina Hospital, Eindhoven, The Netherlands; 3. Department of Urology, Herlev Hospital, Herlev, Denmark; 4. Department of Urology, Lions Kidney Hospital and Urology Research Institute New Friends Colony, New Delhi, India; Department of Urology, AMC University Hospital, Amsterdam, The Netherlands.
Abstract
BACKGROUND: Efficacy and safety of percutaneous nephrolithotomy (PCNL) have been demonstrated in obese individuals. Yet, there is a paucity of data on the outcomes of PCNL in morbidly obese patients (body mass index [BMI] >40). METHODS: Perioperative and stone-related outcomes following PCNL in morbidly obese patients was assessed using a prospective database administered by the Clinical Research Office of the Endourological Society (CROES). A multidimensional match of 97 morbidly obese patients with those of normal weight was created using propensity score matching. Student's t-test and Chi-square tests were used to assess for differences between the groups. RESULTS: In total, 97 patients with a BMI >40 kg/m(2) were matched by stone characteristics with 97 patients of normal weight. The morbidly obese population demonstrated higher rates of diabetes mellitus (43% vs. 6%, p < 0.001) and cardiovascular disease (56% vs. 18%, (p < 0.001). Access was achieved more frequently by radiologists in the morbidly obese group (19% vs. 6%, p = 0.016). Mean operative duration was longer in the morbidly obese group (112 ± 56 min vs. 86 ± 43.5 min, p < 0.001). Stone-free rates were lower in the morbidly obese group (66% vs. 77%, p = 0.071). There was no significant difference in length of hospital stay or transfusion rate. Morbidly obese patients were significantly more likely to experience a postoperative complication (22% vs. 6%, p = 0.004). INTERPRETATION: PCNL in morbidly obese patients is associated with longer operative duration, higher rates of re-intervention and an increased risk of perioperative complications. With this knowledge, urologists should seek to develop strategies to optimize the perioperative management of such patients.
BACKGROUND: Efficacy and safety of percutaneous nephrolithotomy (PCNL) have been demonstrated in obese individuals. Yet, there is a paucity of data on the outcomes of PCNL in morbidly obesepatients (body mass index [BMI] >40). METHODS: Perioperative and stone-related outcomes following PCNL in morbidly obesepatients was assessed using a prospective database administered by the Clinical Research Office of the Endourological Society (CROES). A multidimensional match of 97 morbidly obesepatients with those of normal weight was created using propensity score matching. Student's t-test and Chi-square tests were used to assess for differences between the groups. RESULTS: In total, 97 patients with a BMI >40 kg/m(2) were matched by stone characteristics with 97 patients of normal weight. The morbidly obese population demonstrated higher rates of diabetes mellitus (43% vs. 6%, p < 0.001) and cardiovascular disease (56% vs. 18%, (p < 0.001). Access was achieved more frequently by radiologists in the morbidly obese group (19% vs. 6%, p = 0.016). Mean operative duration was longer in the morbidly obese group (112 ± 56 min vs. 86 ± 43.5 min, p < 0.001). Stone-free rates were lower in the morbidly obese group (66% vs. 77%, p = 0.071). There was no significant difference in length of hospital stay or transfusion rate. Morbidly obesepatients were significantly more likely to experience a postoperative complication (22% vs. 6%, p = 0.004). INTERPRETATION: PCNL in morbidly obesepatients is associated with longer operative duration, higher rates of re-intervention and an increased risk of perioperative complications. With this knowledge, urologists should seek to develop strategies to optimize the perioperative management of such patients.
Authors: Wesley O Ekeruo; Yeh Hong Tan; Matthew D Young; Philipp Dahm; Michaella E Maloney; Barbara J Mathias; David M Albala; Glenn M Preminger Journal: J Urol Date: 2004-07 Impact factor: 7.450
Authors: Igor Sergeyev; Philip T Koi; Stacy L Jacobs; Alla Godelman; David M Hoenig Journal: Surg Laparosc Endosc Percutan Tech Date: 2007-06 Impact factor: 1.719
Authors: J G Valdivia Uría; J Valle Gerhold; J A López López; S Villarroya Rodriguez; C Ambroj Navarro; M Ramirez Fabián; J M Rodriguez Bazalo; M A Sánchez Elipe Journal: J Urol Date: 1998-12 Impact factor: 7.450
Authors: Jeffrey J Leow; Anne-Sophie Valiquette; Benjamin I Chung; Steven L Chang; Quoc-Dien Trinh; Rus Korets; Naeem Bhojani Journal: Can Urol Assoc J Date: 2018-06-19 Impact factor: 1.862
Authors: Akshay Kriplani; Shruti Pandit; Arun Chawla; Jean J M C H de la Rosette; Pilar Laguna; Suraj Jayadeva Reddy; Bhaskar K Somani Journal: Urolithiasis Date: 2022-03-04 Impact factor: 2.861